Skip to main content
. 2022 May 5;11(3):1085–1100. doi: 10.1007/s40120-022-00352-w

Table 2.

ADCOMS scores by clinical group at baseline

Group n Mean SD Observed range
(min–max)
Floor
n(%)
Ceiling
n(%)
Normal cognition
 All 1825 0.06 0.04 0.00–0.48 7 (0.4%) 0 (0.0%)
 APOE ε4 carrier 542 0.06 0.04 0.00–0.34 3 (0.6%) 0 (0.0%)
 APOE ε4 non-carrier 1198 0.05 0.03 0.00–0.48 4 (0.3%) 0 (0.0%)
Impaired (not-MCI)
 All 117 0.15 0.09 0.04–0.48 0 (0.0%) 0 (0.0%)
 APOE ε4 carrier 38 0.17 0.09 0.04–0.38 0 (0.0%) 0 (0.0%)
 APOE ε4 non-carrier 67 0.14 0.08 0.04–0.48 0 (0.0%) 0 (0.0%)
MCI
 All 2001 0.22 0.11 0.03–0.75 0 (0.0%) 0 (0.0%)
 APOE ε4 carrier 885 0.24 0.11 0.04–0.75 0 (0.0%) 0 (0.0%)
 APOE ε4 non-carrier 890 0.21 0.11 0.03–0.71 0 (0.0%) 0 (0.0%)
Dementia
 All 1412 0.64 0.34 0.04–2.01 0 (0.0%) 0 (0.0%)
 APOE ε4 carrier 712 0.63 0.30 0.09–2.01 0 (0.0%) 0 (0.0%)
 APOE ε4 non-carrier 560 0.62 0.33 0.04–2.01 0 (0.0%) 0 (0.0%)

ADCOMS Alzheimer’s Disease Composite Score, MCI mild cognitive impairment, SD standard deviation

APOE ε4 carrier status is missing for n = 463 participants